Clin2
NCT07704424Possibly a fitRecruiting

Testing a heart pump for severe right heart failure

Right Heart Failure

Part of Heart & circulation clinical trials.

This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
6 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have severe right heart failure within 48 hours of heart surgery, a heart attack, or a heart transplant that does not get better with strong medications.
  • Your heart function must meet specific measurements, such as low cardiac index or signs of right heart strain on an ultrasound.
  • You cannot be in critical condition requiring immediate emergency life support (INTERMACS 1).
  • You cannot have severe liver or kidney problems, active infections, blood clots in the heart, or uncontrolled bleeding risk.
  • You cannot be pregnant or breastfeeding, or be in another conflicting clinical trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06267612Not yet recruiting
Long-term study of the Corheart 6 heart pump

This trial looks at how well a small heart pump (Corheart 6 LVAS) works over time for people with severe heart failure that hasn't improved with standard treatments. It aims to help those who need extra support to keep their heart pumping.

Nanjing, Jiangsu
NCT05876000Recruiting
Heart pump study for very severe heart failure

This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.

Graz
NCT06127927Recruiting
Heart pump for severe heart failure

This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.

Fuzhou, Fujian
NCT07675005Not yet recruiting
Testing a new heart pump for high-risk heart patients

This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.

NCT07700810Not yet recruiting
Study of the Corheart 6 left ventricular assist system

This trial tests a heart pump (Corheart 6) for people with severe heart failure who are not getting better with other treatments. It may help if you need a heart assist device.

NCT07233876Not yet recruiting
Testing a new two-sided heart pump for severe heart failure

This trial is testing a new mechanical heart pump designed to support both sides of the heart. You may be eligible if you have advanced, severe heart failure that is not getting better with other treatments.

Hanover

Hear when a new Right Heart Failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.